Supportive Care in Cancer

, Volume 19, Issue 1, pp 141–147 | Cite as

Retrospective trial of complete decongestive physical therapy for lower extremity secondary lymphedema in melanoma patients

Original Article

Abstract

Background

Melanoma is a malignant tumour of melanocytes, which are found predominantly in skin, and at least 10–45% of patients develop secondary lymphedema (SL).

Purpose

This study seeks to investigate if individual’s lymphatic system can benefit from complete decongestive physical therapy (CDPT) 1 year after discharge from CDPT and consequently endorsing a better quality of life.

Methods

Male and female(n = 12) melanoma survivors 1–4 years post diagnosis with unilateral SL. Questionnaire and limb measurements were used to asses retrospective outcomes.

Results

A significant improvements (p < 0.05) has been in the categories of localisation, staging, disability and symptoms of SL.

Conclusions

CDPT provides relief in signs and symptoms for patients with SL following groyne dissection.

Keywords

Lymphedema Melanoma Physical therapy 

References

  1. 1.
    Kroon BB, Nieweg OE (2000) Management of malignant melanoma. Ann Chir Gynaecol 89(3):242–250PubMedGoogle Scholar
  2. 2.
    Rekha A, Ravi A, Venu N, Shivanraj A (2005) Malignant melanoma and filariasis: a coexistence or an association? Int J Low Extrem Wounds 4(1):60–64CrossRefPubMedGoogle Scholar
  3. 3.
    Karakousis CP, Driscoll DL (1999) Treatment and local control of primary extremity soft tissue sarcomas. J Surg Oncol 71(3):155–161CrossRefPubMedGoogle Scholar
  4. 4.
    Brouns E, Donceel P, Stas M (2008) Quality of life and disability after ilio-inguinal lymphadenectomy. Acta Chir Belg 108(6):685–690PubMedGoogle Scholar
  5. 5.
    Campisi C, Boccardo F, Alitta P, Tacchella M (1995) Derivative lymphatic microsurgery: indications, techniques, and results. Microsurgery 16(7):463–468CrossRefPubMedGoogle Scholar
  6. 6.
    Casley-Smith JR (1992) A model of the factors affecting interstitial volume in oedema. Part I: hierarchies, some new factors and their equations. Biorheology 29(5–6):535–548PubMedGoogle Scholar
  7. 7.
    Bowsher WG, Taylor BA, Hughes LE (1986) Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg 73(11):906–908CrossRefPubMedGoogle Scholar
  8. 8.
    Gerber LH (1998) A review of measures of lymphedema. Cancer 83:2803–2804CrossRefPubMedGoogle Scholar
  9. 9.
    Adamsen L, Midtgaard J, Rorth M, Borregaard N, Andersen C, Quist M, Møller T, Zacho M, Madsen JK, Knutsen L (2003) Feasibility, physical capacity, and health benefits of a multidimensional exercise program for cancer patients undergoing chemotherapy. Support Care Cancer 11(11):707–716CrossRefPubMedGoogle Scholar
  10. 10.
    Drake D, Falzer P, Xistris D, Robinson G, Roberge M (2004) Physical fitness training: outcomes for adult oncology patients. Clin Nurs Res 13(3):245–264CrossRefPubMedGoogle Scholar
  11. 11.
    Schwartz AL, Mori M, Gao R, Nail LM, King ME (2001) Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc 33(5):718–723CrossRefPubMedGoogle Scholar
  12. 12.
    Foldi E, Földi M, Clodius L (1989) The lymphedema chaos: a lancet. Ann Plast Surg 22(6):505–515CrossRefPubMedGoogle Scholar
  13. 13.
    Ko DS, Lerner R, Klose G, Cosimi AB (1998) Effective treatment of lymphedema of the extremities. Arch Surg 133(4):452–458CrossRefPubMedGoogle Scholar
  14. 14.
    Shamley DR, Barker K, Simonite V, Beardshaw A (2005) Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat 90(3):263–271CrossRefPubMedGoogle Scholar
  15. 15.
    Jones LW, Courneya KS, Fairey AS, Mackey JR (2004) Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med 28(2):105–113CrossRefPubMedGoogle Scholar
  16. 16.
    Courneya KS, Friedenreich CM, Quinney HA, Fields AL, Jones LW, Fairey AS (2003) A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur J Cancer Care (Engl) 12(4):347–357CrossRefGoogle Scholar
  17. 17.
    Bernas MJ, Witte CL, Witte MH (2001) International society of lymphology executive committee. The diagnosis and treatment of peripheral lymphedema: draft revision of the 1995 consensus document of the international society of lymphology executive committee for discussion at the September 3-7, 2001, XVIII international congress of lymphology in Genoa, Italy. Lymphology 34(2):84–91PubMedGoogle Scholar
  18. 18.
    ISL- International Society of Lymphology The diagnosis and treatment of peripheral lymphedema (2003) Consensus document of the International Society of Lymphology. Lymphology 36(2):84–91Google Scholar
  19. 19.
    Paterson AG, Trask PC, Wagner LI, Esper P, Redman B (2005) Validation of the FACT-BRM with interferon-alpha treated melanoma patients. Qual Life Res 14(1):133–139CrossRefPubMedGoogle Scholar
  20. 20.
    Chiarion-Sileni V, Del Bianco P, De Salvo GL, Lo Re G, Romanini A, Labianca R, Nortilli R, Corgna E, Dalla Palma M, Lo Presti G, Ridolfi R, Italian Melanoma Intergroup (IMI) (2003) Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur J Cancer 39(11):1577–1585CrossRefPubMedGoogle Scholar
  21. 21.
    Mayrovitz HN (2009) The standard of care for lymphedema: current concepts and physiological considerations. Lymphat Res Biol 7(2):101–108CrossRefPubMedGoogle Scholar
  22. 22.
    Horning KM, Guhde J (2007) Lymphedema: an under-treated problem. Medsurg Nurs 16(4):221–227PubMedGoogle Scholar
  23. 23.
    Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21(9):1653–1659CrossRefPubMedGoogle Scholar
  24. 24.
    Jones LW, Courneya KS, Vallance JK, Ladha AB, Mant MJ, Belch AR, Stewart DA, Reiman T (2004) Association between exercise and quality of life in multiple myeloma cancer survivors. Support Care Cancer 12(11):780–788CrossRefPubMedGoogle Scholar
  25. 25.
    Sagen A, Kåresen R, Risberg MA (2009) Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up. Acta Oncol 23:1–9Google Scholar
  26. 26.
    Hayes SC, Reul-Hirche H, Turner J (2009) Exercise and secondary lymphedema: safety, potential benefits, and research issues. Med Sci Sports Exerc 41(3):483–489CrossRefPubMedGoogle Scholar
  27. 27.
    Balch C, Buzaid A, Soong S, Atkins M, Cascinelli N, Coit D, Fleming I, Gershenwald J, Houghton A, Kirkwood J, McMasters K, Mihm M, Morton D, Reintgen D, Ross M, Sober A, Thompson J, Thompson J (2001) Final version of the American joint committee on cancer staging system for cutaneous melanoma. J Clin Oncol 19(16):3635–3648PubMedGoogle Scholar
  28. 28.
    Mak SS, Yeo W, Lee YM, Mo KF, Tse KY, Tse SM, Ho FP, Kwan WH (2008) Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong. Nurs Res 57(6):416–425CrossRefPubMedGoogle Scholar
  29. 29.
    Mayrovitz HN, Sims N, Litwin B, Pfister S (2005) Foot volume estimates based on a geometric algorithm in comparison to water displacement. Lymphology 38(1):20–27PubMedGoogle Scholar
  30. 30.
    Mock V, Pickett M, Ropka ME, Muscari Lin E, Stewart KJ, Rhodes VA, McDaniel R, Grimm PM, Krumm S, McCorkle R (2001) Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract 9(3):119–127CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Tel Aviv UniversityTel AvivIsrael

Personalised recommendations